VEGFA and diabetic retinopathy: Avery [42] et al., Zehetner [43] et al., and Carneiro [44] et al. found that after intravitreal injection of ranibizumab in adult patients with AMD or diabetic retinopathy (DR), serum VEGF did not decrease.